MXenes are a rapidly expanding family of two-dimensional transition metal carbides and nitrides whose exceptional compositional, structural, and surface-chemical tunability has driven rapid growth across materials science, chemistry, physics, and engineering. This roadmap consolidates the current state of MXene research, spanning synthesis, processing, fundamental properties, computation, electrochemical energy storage, biomedical applications, electronics, optoelectronics, membranes, sensing, tribology, and extreme-environment technologies. By identifying key advances, persistent challenges, and emerging opportunities, the roadmap provides a forward-looking outlook for guiding MXenes from laboratory discovery toward transformative applications.
MXenes, an emerging class of two-dimensional van der Waals materials, have become the focus of research, demonstrating exceptional potential in electrochemical, biochemical and electronic applications. This chapter provides a brief overview of MXenes, covering their fundamental characteristics, synthesis methods and current challenges, with particular attention on synthesis methods.
Peptides possess great potential in drug development due to their high selectivity and excellent biocompatibility, while their poor in vivo stability and short half-life limit the practical applications. Peptide-polymer conjugates, by linking peptides with synthetic or natural polymeric materials, significantly improve their pharmacokinetic properties and therapeutic efficacy. This review systematically summarizes the design principle and synthetic strategies of conjugates, including covalent bonding, physical association, and self-assembly mechanisms, and elaborates on their applications in drug delivery, immunotherapy, and tissue engineering. The review also discusses current challenges, such as difficulties in controlling conjugation sites and increased immunogenicity, and envisions the development of responsive intelligent systems to provide a theoretical basis and reference for future clinical translation of peptide-based therapeutics.
What is the function of GATA3 in mouse and human trophectoderm (TE) formation, and does its function differ between species? GATA3 is dispensable for mouse blastocyst formation, whereas GATA3 is suggested to be important for human trophoblast stem cell (TSC) differentiation, resembling TE in vitro. GATA3 and the highly similar transcription factor (TF) GATA2 are key TE markers in mouse and human embryos. Gata3 knockout (KO)/knockdown studies suggested its crucial role in mouse blastocyst formation, with embryos arresting at the morula stage. However, other studies reported lethality only at 11–12 dpf. In human, GATA3 is detected in a subset of morula cells, suggesting an early role in TE formation. Overexpression of GATA2 and GATA3 in human embryonic stem cells (hESCs) drives differentiation into TSCs, indicating their necessity for human TE induction. However, GATA3’s exact function in mouse and human TE formation is still unclear. Gata3 KO mouse embryos were assessed morphologically until E4.5 and immunofluorescent (IF) stained to confirm GATA3’s absence (n = 69). Besides, the impact of the KO on total cell numbers and TE cells was assessed by IF staining Gata3 KO blastocysts for nuclei (n = 16,DAPI) and CDX2 (n = 15, TE marker). Naïve hESCs were targeted for GATA3 with CRISPR/Cas9 and were differentiated towards TSCs (in vitro counterpart of human TE), to check GATA3’s necessity for TSC differentiation/human TE formation. Following delivery of Gata3 targeting CRISPR/Cas9 ribonucleoprotein complexes in mouse zygotes, embryos were cultured and morphologically observed until E4.5, alongside media and Scrambled (inactive gRNA) controls. Targeted embryos were IF stained and genotyped by next generation sequencing. Single-cell RNA sequencing data from Petropoulos et al.(2016) was analyzed to assess GATA3’s expression throughout human preimplantation development, followed by IF of human blastocysts. Naïve hESCs were targeted for GATA3 with CRISPR/Cas9 through nucleofection and differentiated towards TSCs. IF staining of WT mouse embryos (n = 16) revealed that GATA3 is expressed in TE progenitor cells in the morula, and its expression persists until the late blastocyst stage. Majority (94%, n = 65) of Gata3-/- embryos (n = 69) successfully formed blastocysts, with no significant morphological difference compared to Scrambled embryos (n = 148). However, Gata3 -/- mouse embryos showed a reduced number of total cells (n = 16) and CDX2 + (TE marker) cells (n = 15). Single-cell RNA sequencing data of human embryos of Petropoulos et al. (2016) revealed that GATA3 is expressed in a subset of morula cells, increases in early TE progenitors, and persists in the mature TE in human blastocysts. GATA2 (TF highly similar to GATA3) expression onsets later in the early TE and predominates in the mature TE. This suggests an earlier role of GATA3 in the human TE than GATA2, which can be considered as a mature TE marker. IF confirmed GATA3’s expression in the human TE at the blastocyst stage and co-expression with TEAD4, GATA2 and CDX2. Differentiation of mosaic GATA3 KO naïve hESCs towards TSCs (in vitro counterpart of human TE) revealed a hampered differentiation, with some colonies unable to form flattened TSC colonies, suggesting GATA3’s crucial role in human TE differentiation. CRISPR/Cas9 editing faces challenges like mosaicism, off-target effects, and chromosomal rearrangements. In addition, limited availability of human gametes hinders studying the role of GATA3 in the human blastocyst formation. Therefore, in vitro stem cell models are used as a first step to investigate GATA3’s role in human TE/TSC formation. Our goal is to identify the molecular pathways crucial for TE formation in mouse and human embryos. By using CRISPR/Cas9 to generate KO embryos/naïve hESCs, we gain insight into key molecular mechanisms, potentially shedding light on pregnancy failure due to defects in the TE specification, formation or maintenance. No
Decoding the gene regulatory mechanisms mediating self-renewal of hematopoietic stem cells (HSCs) during their amplification in the fetal liver (FL) is relevant for advancing therapeutic applications aiming to expand transplantable HSCs, a long-standing challenge. Here, to explore intrinsic and extrinsic regulation of self-renewal in FL-HSCs at the single cell level, we engineered a culture platform designed to recapitulate the FL endothelial niche, which supports the amplification of serially engraftable HSCs ex vivo. Leveraging this platform in combination with single cell index flow cytometry, serial transplantation assays, and single cell RNA-sequencing, we elucidated previously unrecognized heterogeneity in immunophenotypically defined FL-HSCs and demonstrated that differentiation latency and transcriptional signatures of biosynthetic dormancy are distinguishing properties of self-renewing FL-HSCs with capacity for serial, long-term multilineage hematopoietic reconstitution. Altogether, our findings provide key insights into HSC expansion and generate a novel resource for future exploration of the intrinsic and niche-derived signaling pathways that support FL-HSC self-renewal.